Witzmann F A, Jarnot B M, Clack J W
Department of Biology, IUPUI-Columbus, Indiana 47203.
Appl Theor Electrophor. 1994;4(2):81-8.
This investigation was conducted to determine the comparative effect of structurally diverse peroxisome proliferators (PP) on the two-dimensional protein pattern of rat liver whole homogenates. Perfluoro-n-decanoic acid (PFDA), perfluoro-n-octanoic acid (PFOA), clofibrate, and di(2-ethylhexyl)phthalate(DEHP) are all known to cause the proliferation of hepatic peroxisomes and the induction of peroxisomal beta-oxidative and microsomal omega-oxidative enzymes. To detect potential differences between these compounds with regard to the liver, we examined the unique patterns of protein alteration produced by in vivo exposure to them. Following exposure to various doses, whole liver homogenates were prepared and separated by two-dimensional gel electrophoresis (2DE) using the ISO-DALT System. Stained gels were digitized and protein patterns analyzed using the Kepler 2D Gel Analysis System. Immunoglobulin heavy-chain binding protein (BiP), also known as 78 kD glucose regulated protein (Grp78), was identified immunologically and by comigration of recombinant Grp78. BiP is a luminal endoplasmic reticular (ER) protein that functions in the assembly and folding of nascent proteins as they enter the ER. The present results suggest a selective posttranslational modification of BiP following PFDA exposure. Single-dose exposure to PFDA was associated with a notable charge-modification of BiP that persists up to 30 days. PFOA, clofibrate, and DEHP had less effect in this regard. Our data suggest the likely nature of this PFDA-associated protein modification is associated with protein-phosphorylation. These results document the unique nature of PFDA's hepatotoxicity with respect to classic peroxisome proliferators and support the utility of 2D gel analysis in toxicity testing.
本研究旨在确定结构各异的过氧化物酶体增殖剂(PP)对大鼠肝脏全匀浆二维蛋白质图谱的比较影响。全氟正癸酸(PFDA)、全氟正辛酸(PFOA)、氯贝丁酯和邻苯二甲酸二(2-乙基己基)酯(DEHP)均已知可导致肝脏过氧化物酶体增殖,并诱导过氧化物酶体β-氧化和微粒体ω-氧化酶。为检测这些化合物在肝脏方面的潜在差异,我们研究了体内暴露于它们后产生的独特蛋白质改变模式。暴露于各种剂量后,制备全肝匀浆,并使用ISO-DALT系统通过二维凝胶电泳(2DE)进行分离。对染色后的凝胶进行数字化处理,并使用开普勒二维凝胶分析系统分析蛋白质图谱。免疫球蛋白重链结合蛋白(BiP),也称为78 kD葡萄糖调节蛋白(Grp78),通过免疫鉴定和重组Grp78的共迁移进行鉴定。BiP是一种内质网腔蛋白,在新生蛋白质进入内质网时参与组装和折叠。目前的结果表明,PFDA暴露后BiP发生了选择性的翻译后修饰。单剂量暴露于PFDA与BiP显著的电荷修饰有关,这种修饰可持续长达30天。在这方面,PFOA、氯贝丁酯和DEHP的影响较小。我们的数据表明,这种与PFDA相关的蛋白质修饰可能的性质与蛋白质磷酸化有关。这些结果证明了PFDA相对于经典过氧化物酶体增殖剂的肝毒性的独特性质,并支持二维凝胶分析在毒性测试中的实用性。